Nitric Oxide Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells by Inhibiting the Drug Efflux

Chiara Riganti, Erica Miraglia, Daniele Viarisio, +4

Cancer Research

OncologyDoxorubicin ResistanceHealth SciencesOncogenic AgentNitric Oxide +13

Diphenyleneiodonium Inhibits the Cell Redox Metabolism and Induces Oxidative Stress

Chiara Riganti, Elena Gazzano, Manuela Polimeni, +3

Journal of Biological Chemistry

Cytotoxicity of zinc-containing bioactive glasses in contact with human osteoblasts

Valentina Aina, Alessandra Perardi, Loredana Bergandi, +4

Chemico-Biological Interactions

OphthalmologyBioactive MetalZinc-containing Bioactive GlassesBiomedical EngineeringMedicine +2

HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast

Sophie Doublier, Dimas Carolina Belisario, Manuela Polimeni, +6

BMC Cancer

Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF‐kB activation

Elisabetta Aldieri, Daniela Atragene, Loredana Bergandi, +4

FEBS Letters

In vitro study of manganese-doped bioactive glasses for bone regeneration

Marta Miola, Chiara Vitale‐Brovarone, Giovanni Maina, +8

Materials Science and Engineering C

Tissue EngineeringRegenerative MedicineEngineeringManganese-doped Bioactive GlassesRegenerative Biomaterials +7

Insulin Stimulates Nitric Oxide Synthesis in Human Platelets and, Through Nitric Oxide, Increases Platelet Concentrations of Both Guanosine-3′, 5′-Cyclic Monophosphate and Adenosine-3′, 5′-Cyclic Monophosphate

Mariella Trovati, Giovanni Anfossi, Paola Massucco, +7

Diabetes

Metabolic SyndromeHuman PlateletsHealth SciencesBiochemistryBlood Platelet +12

Sr-containing hydroxyapatite: morphologies of HA crystals and bioactivity on osteoblast cells

Valentina Aina, Loredana Bergandi, Gigliola Lusvardi, +5

Materials Science and Engineering C

Ha CrystalsEngineeringHydroxyapatiteMedicineBiomineralization +10

Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells

Joanna Kopecka, Ivana Campia, Andreas P. Frei, +3

Oncotarget

New Therapeutic TargetTumor BiologyCell SurfaceAnti-cancer AgentCancer Research +14

Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium‐dependent activation of HIF‐1α and P‐glycoprotein overexpression

Chiara Riganti, Sophie Doublier, Daniele Viarisio, +4

British Journal of Pharmacology